Annals of Family Medicine

NOVEMBER 20, 2024

Objective To evaluate the association between patient, health system, geosocial, and environmental factors on the likelihood of MA in Family Medicine clinics. Setting Family medicine clinics in an academic medical center in southcentral Pennsylvania.

Appointment 130

Appointment Primary Care Family Medicine DO 130

Annals of Family Medicine

NOVEMBER 20, 2024

Setting or Dataset We utilized the 2019 and 2021 National Health Interview Survey data (NHIS), which collects information about health, healthcare access, and health behaviors, including CCS. Study Design and Analysis This was an observational retrospective study examining Black and White women as the predictive variable and CCS outcomes.

Screening 130

Screening Utilities Patient-Centered Insurance 130

The Health Policy Exchange

SEPTEMBER 2, 2020

Health Policy Fellowship three years ago, though I still enjoy working alongside these talented family physicians in clinic, such as Dr. Brian Antono, who recently blogged about his fellowship experiences for Harvard Medical School's Center for Primary Care. I stepped down as director of the Robert L. Phillips, Jr.

Primary Care 130

Primary Care Primary Care Physician Patient-Centered Behavioral Health Services 130

FDA Law Blog

AUGUST 12, 2021

Biosimilars do provide a more affordable way for sponsors to get products onto the market—by referencing the clinical studies performed by the reference product sponsor—which, in theory, allows for the introduction of lower cost versions of expensive biologics.

Clinic 98

Clinic Provider IT Patients 98

The Clinical Problem Solvers

APRIL 3, 2023

Although healthcare services are publicly funded, access to medications depends on private or public insurance and is linked with employment. Cambridge: Cambridge University Press; 2019:185-194. Racialised people in clinical guideline panels. doi:10.1017/9781108646208.011 Browne AJ, Lavoie JG, McCallum MJL, Canoe CB.

Medical 52

Medical Healthcare Individual Community 52

FDA Law Blog

JANUARY 6, 2022

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs is primarily compensated by patient’s insurance providers. 18 U.S.C. §

Lab Testing 52

Lab Testing Individual Referral Patient-Centered 52

FDA Law Blog

JANUARY 6, 2022

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs is primarily compensated by patient’s insurance providers. 18 U.S.C. §

Lab Testing 40

Lab Testing Individual Referral Patient-Centered 40